Diamant Asset Management Inc. Purchases 332,040 Shares of Zoetis Inc. $ZTS

Diamant Asset Management Inc. raised its position in shares of Zoetis Inc. (NYSE:ZTS) by 10,763.0% in the 1st quarter, Holdings Channel reports. The firm owned 335,125 shares of the company’s stock after acquiring an additional 332,040 shares during the period. Diamant Asset Management Inc.’s holdings in Zoetis were worth $39,615,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Global Wealth Strategies & Associates bought a new position in shares of Zoetis in the 4th quarter valued at $25,000. Prosperity Bancshares Inc acquired a new position in shares of Zoetis during the 4th quarter worth $25,000. KERR FINANCIAL PLANNING Corp bought a new stake in shares of Zoetis during the 3rd quarter worth $31,000. Lodestone Wealth Management LLC bought a new stake in shares of Zoetis during the 4th quarter worth $30,000. Finally, Elyxium Wealth LLC acquired a new stake in Zoetis in the fourth quarter valued at about $32,000. 92.80% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ZTS. Morgan Stanley reissued an “overweight” rating and issued a $115.00 target price on shares of Zoetis in a report on Friday, May 15th. Argus reaffirmed a “hold” rating on shares of Zoetis in a report on Wednesday, May 27th. Leerink Partners reiterated a “market perform” rating on shares of Zoetis in a research report on Tuesday, March 10th. William Blair reissued an “outperform” rating on shares of Zoetis in a research note on Monday, March 2nd. Finally, UBS Group cut their target price on shares of Zoetis from $130.00 to $99.00 and set a “neutral” rating on the stock in a research report on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Zoetis has an average rating of “Hold” and an average target price of $133.08.

Zoetis Price Performance

Shares of ZTS opened at $76.05 on Friday. The company has a quick ratio of 1.91, a current ratio of 3.15 and a debt-to-equity ratio of 2.80. The stock has a market cap of $31.88 billion, a PE ratio of 12.61, a PEG ratio of 1.19 and a beta of 0.75. Zoetis Inc. has a 12-month low of $72.38 and a 12-month high of $161.77. The business has a 50-day simple moving average of $88.70 and a two-hundred day simple moving average of $110.94.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, May 7th. The company reported $1.53 EPS for the quarter, missing analysts’ consensus estimates of $1.60 by ($0.07). The firm had revenue of $2.26 billion for the quarter, compared to analyst estimates of $2.30 billion. Zoetis had a net margin of 27.80% and a return on equity of 66.85%. The business’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the business posted $1.48 earnings per share. Zoetis has set its FY 2026 guidance at 6.850-7.000 EPS. Analysts anticipate that Zoetis Inc. will post 6.88 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Investors of record on Monday, July 20th will be given a dividend of $0.53 per share. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.8%. Zoetis’s dividend payout ratio (DPR) is currently 35.16%.

Insiders Place Their Bets

In other Zoetis news, Director Frank A. Damelio purchased 6,650 shares of the company’s stock in a transaction dated Wednesday, May 13th. The stock was purchased at an average price of $75.39 per share, with a total value of $501,343.50. Following the completion of the purchase, the director owned 21,458 shares of the company’s stock, valued at approximately $1,617,718.62. The trade was a 44.91% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Paul Bisaro purchased 2,000 shares of the business’s stock in a transaction dated Wednesday, May 13th. The shares were acquired at an average price of $75.88 per share, for a total transaction of $151,760.00. Following the acquisition, the director owned 27,862 shares of the company’s stock, valued at $2,114,168.56. This trade represents a 7.73% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired 11,650 shares of company stock valued at $886,384 in the last ninety days. 0.22% of the stock is currently owned by insiders.

More Zoetis News

Here are the key news stories impacting Zoetis this week:

• Negative Sentiment: Multiple firms, including Rosen Law Firm, Glancy Prongay Wolke & Rotter, Bronstein Gewirtz & Grossman, and others, announced or promoted class-action claims against Zoetis, increasing legal overhang and sentiment pressure on the stock.
• Neutral Sentiment: Zoetis also said it will host a webcast and conference call on August 6, 2026 to discuss second-quarter results, which may provide a more fundamental update for investors. Article Title

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.